Vancomycin-resistant Enterococcus in pediatric oncology patients: balancing infection prevention and family-centered care.
J Pediatr Hematol Oncol
; 35(3): 227-31, 2013 Apr.
Article
em En
| MEDLINE
| ID: mdl-22627579
ABSTRACT
In February 2007, we experienced an abrupt 8-fold increase in vancomycin-resistant Enterococcus (VRE)-positive pediatric hematology/oncology patients in isolation per day, peaking at 12 patients in isolation per day in June 2007. We enforced and expanded infection prevention practices and initiated a rigorous 6-month clearance process. After noting an eventual decrease, we modified clearance to a 3-month process, maintaining <1 patient/day in isolation by June 2009, subjectively improving family and staff satisfaction after this 2-year process. VRE infection was relatively uncommon (7.8%), although continued VRE colonization portended an overall poorer prognosis.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Surtos de Doenças
/
Serviço Hospitalar de Oncologia
/
Controle de Infecções
/
Infecções por Bactérias Gram-Positivas
/
Enterococcus
/
Assistência Centrada no Paciente
/
Resistência a Vancomicina
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Child
/
Humans
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article